Nanobiotix SA
NBTX19.870USD
+0.200+1.02%
終値 11/07, 16:00（ET）15分遅れの株価
958.02M時価総額
--直近12ヶ月PER
詳細情報 Nanobiotix SA 企業名
Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
Nanobiotix SAの企業情報
企業コードNBTX
会社名Nanobiotix SA
上場日Oct 29, 2012
最高経営責任者「CEO」Dr. Laurent Levy, Ph.D.
従業員数108
証券種類Depository Receipt
決算期末Oct 29
本社所在地60 rue de Wattignies
都市PARIS
証券取引所NASDAQ Global Select Consolidated
国France
郵便番号75012
電話番号33140260470
ウェブサイトhttps://www.nanobiotix.com
企業コードNBTX
上場日Oct 29, 2012
最高経営責任者「CEO」Dr. Laurent Levy, Ph.D.
Nanobiotix SAの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Laurent Levy, Ph.D.
Dr. Laurent Levy, Ph.D.
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Bart Van Rhijn
Mr. Bart Van Rhijn
Chief Financial & Business Officer
Chief Financial & Business Officer
--
--
Ms. Anne-Marie Graffin
Ms. Anne-Marie Graffin
Independent Vice Chairwoman of the of the Board
Independent Vice Chairwoman of the of the Board
--
--
Ms. Anne-Juliette Hermant
Ms. Anne-Juliette Hermant
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Dr. Gary M. Phillips, M.D.
Dr. Gary M. Phillips, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Craig West
Mr. Craig West
Senior Vice President - Investor Relations
Senior Vice President - Investor Relations
--
--
Mr. Enno Spillner
Mr. Enno Spillner
Independent Director
Independent Director
--
--
Dr. Alain Herrera
Dr. Alain Herrera
Independent Director
Independent Director
--
--
Dr. Louis Kayitalire, M.D.
Dr. Louis Kayitalire, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Brandon Owens
Mr. Brandon Owens
Vice President - Strategic Marketing and Corporate Communications
Vice President - Strategic Marketing and Corporate Communications
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Laurent Levy, Ph.D.
Dr. Laurent Levy, Ph.D.
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Bart Van Rhijn
Mr. Bart Van Rhijn
Chief Financial & Business Officer
Chief Financial & Business Officer
--
--
Ms. Anne-Marie Graffin
Ms. Anne-Marie Graffin
Independent Vice Chairwoman of the of the Board
Independent Vice Chairwoman of the of the Board
--
--
Ms. Anne-Juliette Hermant
Ms. Anne-Juliette Hermant
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Dr. Gary M. Phillips, M.D.
Dr. Gary M. Phillips, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Craig West
Mr. Craig West
Senior Vice President - Investor Relations
Senior Vice President - Investor Relations
--
--
収益内訳
データなし
データなし
事業別
地域別
データなし
株主
更新時刻: Tue, Aug 19
更新時刻: Tue, Aug 19
株主統計
種類
株主統計
株主統計
比率
Johnson & Johnson Innovation-JJDC, Inc.
11.66%
Geode Capital Management, L.L.C.
0.02%
Morgan Stanley & Co. International Plc
0.01%
他の
88.30%
株主統計
株主統計
比率
Johnson & Johnson Innovation-JJDC, Inc.
11.66%
Geode Capital Management, L.L.C.
0.02%
Morgan Stanley & Co. International Plc
0.01%
他の
88.30%
種類
株主統計
比率
Venture Capital
11.66%
Investment Advisor/Hedge Fund
0.02%
Research Firm
0.01%
Investment Advisor
0.01%
他の
88.29%
機関投資家保有株
更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
27
5.65M
11.71%
-4.13M
2025Q2
25
5.76M
12.15%
-4.19M
2025Q1
25
5.76M
12.15%
-4.19M
2024Q4
25
6.07M
12.79%
-4.24M
2024Q3
21
6.42M
13.54%
-3.89M
2024Q2
22
9.30M
19.73%
-1.04M
2024Q1
21
9.31M
19.76%
-988.94K
2023Q4
21
9.28M
19.68%
+1.01M
2023Q3
16
4.47M
12.36%
+481.67K
2023Q2
12
3.47M
9.94%
-1.27M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Johnson & Johnson Innovation-JJDC, Inc.
5.62M
11.66%
--
--
Jun 30, 2025
Geode Capital Management, L.L.C.
10.18K
0.02%
--
--
Jun 30, 2025
Morgan Stanley & Co. International Plc
5.30K
0.01%
-800.00
-13.11%
Jun 30, 2025
UBS Financial Services, Inc.
4.42K
0.01%
+1.42K
+47.27%
Jun 30, 2025
BNP Paribas Securities Corp. North America
761.00
0%
+100.00
+15.13%
Jun 30, 2025
EverSource Wealth Advisors, LLC
517.00
0%
+517.00
--
Jun 30, 2025
RBC Capital Markets Wealth Management
125.00
0%
-11.00
-8.09%
Jun 30, 2025
Rhumbline Advisers Ltd. Partnership
33.00
0%
--
--
Jun 30, 2025
Perceptive Advisors LLC
--
0%
-105.05K
-100.00%
Jun 30, 2025
詳細を見る
関連ETF
更新時刻: Thu, Nov 6
更新時刻: Thu, Nov 6
銘柄名
比率
iShares Biotechnology ETF
0%
iShares Biotechnology ETF
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
